Benefits of Unani medicine in common cold
- Conditions
- Health Condition 1: J309- Allergic rhinitis, unspecified
- Registration Number
- CTRI/2023/06/053622
- Lead Sponsor
- ational Institute of Unani Medicine Bangalore
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Age between 18-60 years
2. All genders
3. All cases of allergic rhinitis according to ARIA classification
4. Subjects with both intermittent and/or persistent allergic rhinitis and having at least two of the following rhinitis-associated conditions: nasal congestion, rhinorrhea, sneezing and nasal itching.
5. Patients who will give consent and able to do follow up
1. Subjects having Nasal polyps, Sinusitis, Atrophic rhinitis, Hypertrophied turbinates,Deviated nasal septum, and congenital nasal abnormalities like nasal dermoid cysts,
congenital midline nasal masses etc.
2. Subjects with a history of heart diseases, kidney diseases, liver diseases, DM,Malignancy, and severe asthma.
3. Subjects who had received systematically or topically administered corticosteroids,
antihistamines, or decongestants 07 days prior to enrolment
4. Personnel who are taking part in other clinical trials
5. Subjects with known allergy from the ingredients of trial interventions
6. Pregnant and lactating women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in Rhino-conjunctivitis Total Symptom Score (RCTSS)Timepoint: 4 weeks
- Secondary Outcome Measures
Name Time Method 1.Reduction in SNOT-22 score <br/ ><br>2.Improvement in subjective parameters <br/ ><br>3. AECTimepoint: 4 WEEKS